Posts

Psychedelic Business Spotlight - June 17

Psychedelic Business Spotlight – June 17

, ,
This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!

Psychedelic Business Spotlight – June 10

,
This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon; Numinus completed the acquisition of Novamind, MindMed's stock is removed from an index; and...
Psychedelic Business Spotlight - May 20

Psychedelic Business Spotlight – May 20

,
This week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good news for alcohol abuse treatment.
Shutterstock

Elon Musk Excites Psychedelic Industry CEOs with This Tweet

,
This is one of the billionaire's most explicit acknowledgments of the power of psychedelics for mental health applications.

Psychedelic Business Spotlight – April 15

,
This week in psychedelic business news: The industry's first major merger; NeonMind launches clinics; a portfolio of patents is acquired.
Numinus Acquiring Novamind in First Major Psychedelics MergerShutterstock

Numinus Acquiring Novamind in First Major Psychedelics Merger

,
This deal will make Numinus the psychedelic medicines company with the highest revenue, though of course there is still a long road to profitability.

Psychedelic Business Spotlight – February 4

,
Levitee Labs Announces Interim CEO and Board of Directors ShuffleThis week in psychedelic business news, Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7), a psychedelic medicine and wellness...
Health Canada Grants Special Access to Restricted Drugs for Psychedelic TherapyShutterstock

Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy

New amendment reverses a 2013 Health Canada policy that prevented "a letter of authorization for a new drug that is or that contains a restricted drug."

Psychedelic Business Spotlight: December 3

,
This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a Cybin study for Covid-19 distress; Compass Pathways gets new majority stakeholder.

Psychedelic Business Spotlight: November 12

,
This week in psychedelic business news: two of the biggest players in the industry unveil big data; Numinus Wellness helps MAPS expand MDMA study; and Ketamine One announces IPO...